Need immediate assistance? Call 1-518-730-0559 (Us-Canada Toll Free) or Contact Us

 

Pain Management Therapeutics Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2025

Table of Content

Section 1 Preface
1.1 Report Scope
1.2 Market Segmentation 
1.3 Research Highlights

Section 2 Assumptions and Research Methodology
2.1 Assumptions
2.2 Acronyms Used
2.3 Research Methodology

Section 3 Executive Summary

Section 4 Market Overview
4.1 Product Overview
4.2 Key Industry Developments
4.3 Market Opportunity Map
4.4 Porter’s Analysis 
4.5 Global Pain Management Therapeutics Market Outlook

Section 5 Market Dynamics
5.1 Drivers and Restraints Snapshot Analysis
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Trends
5.6 Most Types of Body Pain Location Globally and Cut by Gender and Parents 
5.7 Pain Management Therapeutics Pipeline Analysis – Snapshot 
5.8 Opioids with FDA-Approved Labeling Describing Abuse-Deterrent Properties 
5.9 Global Pain Management Therapeutics Market Value (Revenue)
5.10 Pain Management Therapeutics Market Outlook

Section 6 Pain Management Therapeutics Market Analysis, by Therapeutics Type
6.1 Key Findings
6.2 Introduction
6.3 Global Pain Management Therapeutics Market Value Share Analysis, by Therapeutics Type
6.4 Global Pain Management Therapeutics Market Forecast, by Therapeutics Type
       6.4.1 Global Pain Management Therapeutics Market Value Share Analysis, by Opioids
       6.4.2 Global Pain Management Therapeutics Market Forecast, by Opioids 
       6.4.3 Global Anticonvulsants Therapeutics Market, US$ Mn, 2015–2025
       6.4.4 Global Antidepressants Therapeutics Market, US$ Mn, 2015–2025
       6.4.5 Global Anesthetics Therapeutics Market, US$ Mn, 2015–2025
       6.4.6 Global NSAIDs Therapeutics Market, US$ Mn, 2015–2025
       6.4.7 Global Opioids Therapeutics Market, US$ Mn, 2015–2025
       6.4.8 Global Ant migraine Agents Therapeutics Market, US$ Mn, 2015–2025
       6.4.9 Global Other Non-narcotic Analgesics Therapeutics Market, US$ Mn, 2015–2025
6.5 Global Pain Management Therapeutics Market Analysis, by Therapeutics
6.6 Global Pain Management Therapeutics Market Attractiveness Analysis, by Therapeutics

Section 7 Global Pain Management Therapeutics Market Analysis, by Indication
7.1 Key Findings
7.2 Introduction
7.3 Global Pain Management Therapeutics Market Value Share Analysis, By Indication, 2016 and 2025
7.4 Global Pain Management Therapeutics Market Size (US$ Mn) Forecast, By Indication, 2015–2025
       7.4.1 Global Neuropathic Pain Market, US$ Mn, 2015–2025
       7.4.2 Global Fibromyalgia Market, US$ Mn, 2015–2025
       7.4.3 Global Arthritic Pain Market, US$ Mn, 2015–2025
       7.4.4 Global Chronic Back Pain Market, US$ Mn, 2015–2025
       7.4.5 Global Migraine Market, US$ Mn, 2015–2025
       7.4.6 Global Post-Operative Pain Market, US$ Mn, 2015–2025
       7.4.7 Global Cancer Pain Market, US$ Mn, 2015–2025
7.5 Global Pain Management Therapeutics Market Attractiveness By Indication

Section 8 Pain Management Therapeutics Market Analysis, by Region
8.1 Global Scenario, by Country
8.2 Global Pain Management Therapeutics Market Value Share Analysis By Region, 2016 and 2025
8.3 Global Pain Management Therapeutics Market Size (US$ Mn) Forecast, By Region, 2015–2025
8.4 Global Pain Management Therapeutics Market Attractiveness Analysis, by Region

Section 9 North America Pain Management Therapeutics Market Analysis
9.1 Key Findings
9.2 North America Pain Management Therapeutics Market Size (US$ Mn) Forecast, 2017–2025
9.3 North America Market Attractiveness Analysis, by Country
9.4 North America Market Value Share Analysis, by Country, 2017 and 2025
9.5 North America Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Country Type, 2015–2025
9.4 North America Market Value Share Analysis, by Therapeutics, 2017 and 2025
9.5 North America Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Therapeutics Type, 2015–2025
       9.5.1 North America Pain Management Therapeutics Market Value Share Analysis, by Opioids       
       9.5.2 North America Pain Management Therapeutics Market Forecast, by Opioids
9.6 North America Market Value Share Analysis, by Indication, 2017 and 2025
9.7 North America Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Indication Type, 2015–2025
9.8 North America Pain Management Therapeutics Market Attractiveness Analysis, by Therapeutics
9.9 North America Pain Management Therapeutics Market Attractiveness Analysis, by Indication

Section 10 Europe Pain Management Therapeutics Market Analysis
10.1 Key Findings
10.2 Europe Pain Management Therapeutics Market Size (US$ Mn) Forecast, 2017–2025
10.3 Europe Market Attractiveness Analysis, by Country
10.4 Europe Market Value Share Analysis, by Country, 2017 and 2025
10.5 Europe Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Country Type, 2015–2025
       10.5.1 Europe Pain Management Therapeutics Market Value Share Analysis, by Opioids
       10.5.2 Europe Pain Management Therapeutics Market Forecast, by Opioids
10.6 Europe Market Value Share Analysis, by Indication, 2017 and 2025
10.7 Europe Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Indication Type, 2015–2025
10.8 Europe Pain Management Therapeutics Market Attractiveness Analysis, by Therapeutics
10.9 Europe Pain Management Therapeutics Market Attractiveness Analysis, by Indication

Section 11 Asia Pacific Pain Management Therapeutics Market Analysis
11.1 Key Findings
11.2 Asia Pacific Pain Management Therapeutics Market Size (US$ Mn) Forecast, 2017–2025
11.3 Asia Pacific Market Attractiveness Analysis, by Country
11.4 Asia Pacific Market Value Share Analysis, by Country, 2017 and 2025
11.5 Asia Pacific Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Country Type, 2015–2025
       11.5.1 Asia Pacific Pain Management Therapeutics Market Value Share Analysis, by Opioids
       11.5.2 Asia Pacific Pain Management Therapeutics Market Forecast, by Opioids
11.6 Asia Pacific Market Value Share Analysis, by Indication, 2017 and 2025
11.7 Asia Pacific Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Indication Type, 2015–2025
11.8 Asia Pacific Pain Management Therapeutics Market Attractiveness Analysis, by Therapeutics
11.9 Asia Pacific Pain Management Therapeutics Market Attractiveness Analysis, by Indication

Section 12 Rest of the World Pain Management Therapeutics Market Analysis
12.1 Key Findings
12.2 Rest of the World Pain Management Therapeutics Market Size (US$ Mn) Forecast, 2017–2025
12.3 Rest of the World Market Value Share Analysis, by Therapeutics, 2017 and 2025
12.4 Rest of the World Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Therapeutics Type, 2015–2025
       12.4.1 Rest of the World Pain Management Therapeutics Market Value Share Analysis, by Opioids
       12.4.2 Rest of the World Pain Management Therapeutics Market Forecast, by Opioids
12.5 Rest of the World Market Value Share Analysis, by Indication, 2017 and 2025
12.6 Rest of the World Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Indication Type, 2015–2025
12.7 Rest of the World Pain Management Therapeutics Market Attractiveness Analysis, by Therapeutics
12.8 Rest of the World Pain Management Therapeutics Market Attractiveness Analysis, by Indication

Section 13 Competition Landscape
13.1 Competition Matrix
13.2 Heat Map Analysis
13.3 Company Profiles
       13.3.1 Pfizer Inc.
                 13.3.1.1 Company Details
                 13.3.1.2 Business Overview
                 13.3.1.3 Financial Overview
                 13.3.1.4 Strategic Overview
                 13.3.1.5 SWOT Analysis
       13.3.2 Depomed, Inc.
                 13.3.2.1 Company Details
                 13.3.2.2 Business Overview
                 13.3.2.3 Financial Overview
                 13.3.2.4 Strategic Overview
                 13.3.2.5 SWOT Analysis
       13.3.3 Endo International plc.
                 13.3.3.1 Company Details
                 13.3.3.2 Business Overview
                 13.3.3.3 Financial Overview
                 13.3.3.4 Strategic Overview
                 13.3.3.5 SWOT Analysis
       13.3.4 Purdue Pharma L.P.
                 13.3.4.1 Company Details
                 13.3.4.2 Business Overview
                 13.3.4.3 Financial Overview
                 13.3.4.4 Strategic Overview
                 13.3.4.5 SWOT Analysis
       13.3.5 Mallinckrodt Pharmaceuticals
                 13.3.5.1 Company Details
                 13.3.5.2 Business Overview
                 13.3.5.3 Financial Overview
                 13.3.5.4 Strategic Overview
                 13.3.5.5 SWOT Analysis
       13.3.6 Teva Pharmaceutical Industries Ltd.
                 13.3.6.1 Company Details
                 13.3.6.2 Business Overview
                 13.3.6.3 Financial Overview
                 13.3.6.4 Strategic Overview
                 13.3.6.5 SWOT Analysis
       13.3.7 Novartis AG
                 13.3.7.1 Company Details
                 13.3.7.2 Business Overview
                 13.3.7.3 Financial Overview
                 13.3.7.4 Strategic Overview
                 13.3.7.5 SWOT Analysis
       13.3.8 AstraZeneca plc.
                 13.3.8.1 Company Details
                 13.3.8.2 Business Overview
                 13.3.8.3 Financial Overview
                 13.3.8.4 Strategic Overview
                 13.3.8.5 SWOT Analysis
       13.3.9 Johnson & Johnson Services, Inc.
                 13.3.9.1 Company Details
                 13.3.9.2 Business Overview
                 13.3.9.3 Financial Overview
                 13.3.9.4 Strategic Overview
                 13.3.9.5 SWOT Analysis
       13.3.10 Merck & Co., Inc.
                 13.3.10.1 Company Details
                 13.3.10.2 Business Overview
                 13.3.10.3 Financial Overview
                 13.3.10.4 Strategic Overview
                 13.3.10.5 SWOT Analysis
       13.3.11 Abbott Laboratories
                 13.3.11.1 Company Details
                 13.3.11.2 Business Overview
                 13.3.11.3 Financial Overview
                 13.3.11.4 Strategic Overview
                 13.3.11.5 SWOT Analysis
       13.3.12 GlaxoSmithKline plc.
                 13.3.11.1 Company Details
                 13.3.11.2 Business Overview
                 13.3.11.3 Financial Overview
                 13.3.11.4 Strategic Overview
                 13.3.11.5 SWOT Analysis

Custom Market Research Services

MRRSE offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Get A Free Custom Research Quote